Core Viewpoint - The company achieved significant financial growth in the past year, with a notable increase in total revenue and a turnaround in net profit, indicating strong operational performance and potential for future growth [1] Financial Performance - The company reported total revenue of RMB 13.0415 billion, representing a year-on-year increase of 38.4% [1] - The International Financial Reporting Standards (IFRS) net profit reached RMB 813.6 million, recovering from a loss of RMB 94.63 million in the previous year [1] - The Non-IFRS net profit surged to RMB 1.7231 billion, marking a substantial year-on-year growth of 419.6% [1]

Core Viewpoint - Waters Corporation reported a strong financial performance for Q3 2025, with sales reaching $800 million, reflecting an 8% growth compared to $740 million in the same period of 2024 [1] Group 1: Financial Performance - The company achieved over 20% growth in business driven by increased R&D investments from Chinese contract development and manufacturing organizations (CDMO) and biotechnology clients [1] - In the academic and government markets, Waters Corporation also experienced nearly 20% robust growth in China [1] - The company raised its full-year sales growth guidance for 2025 to a range of +6.7% to +7.3% at constant currency [1] Group 2: Management Commentary - Dr. Udit Batra, President and CEO of Waters Corporation, expressed pride in the frontline team in China for successfully launching new products and demonstrating exceptional operational efficiency in a changing environment [1]